Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,084.27%
#4 Black Phoenix Black Phoenix +336.48%
#5 aPriori aPriori +113.53%
#6 Bedrock Bedrock +74.54%
#7 Cysic Cysic +46.36%
#8 Prom Prom +40.86%
#9 Playnance Playnance +34.97%
#10 COTI COTI +30.93%
Coin of the day
Wrapped One Wrapped One
Settings
Language
ENGLISH
Currency
USD
Theme
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Rank in Stocks #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Share Price
$0.00023723
Last synced: 2024-08-26
Market Cap
$1.41K
Change (1 day)
111.67%
Change (1 year)
0.00%
Country
FR
Trade Pharnext S.A. (ALPHA)

Category

Healthcare
Operating Margin for Pharnext S.A. (ALPHA)
Operating Margin as of August 2026 TTM: -238,875.82%
According to Pharnext S.A. latest financial reports and stock price the company's current Operating Margin (TTM) is -238,875.82%. At the end of 2022 the company had an Operating Margin of -5,389,847.67%.
Operating Margin history for Pharnext S.A. from 2012 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -238,875.82% 0.00%
2023 -238,875.82% -95.57%
2022 -5,389,847.67% 17,251.29%
2021 -31,063.10% -42.94%
2020 -54,441.83% 488.85%
2019 -9,245.42% 3,425.69%
2018 -262.23% -59.46%
2017 -646.78% 64.72%
2016 -392.66% 19.72%
2015 -327.99% 15.64%
2014 -283.64% -15.22%
2013 -334.56% 0.00%
2012 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -100.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.00%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.